Clinical trials to continue the development of a liver dialysis device to treat those with life-threatening liver disease have been funded by a grant awarded to UCL, the Royal Free Hospital and Yaqrit.
FDA fast-tracks Invectys’ CAR-T therapy for renal cell carcinoma – Pharmaceutical Technology
The FDA has fast-tracked Invectys’ CAR-T therapy in renal cell carcinoma. Credit: Nemes Laszlo via Shutterstock. The US Food and Drug Administration (FDA) has granted